Cargando…
PGxO and PGxLOD: a reconciliation of pharmacogenomic knowledge of various provenances, enabling further comparison
BACKGROUND: Pharmacogenomics (PGx) studies how genomic variations impact variations in drug response phenotypes. Knowledge in pharmacogenomics is typically composed of units that have the form of ternary relationships gene variant – drug – adverse event. Such a relationship states that an adverse ev...
Autores principales: | Monnin, Pierre, Legrand, Joël, Husson, Graziella, Ringot, Patrice, Tchechmedjiev, Andon, Jonquet, Clément, Napoli, Amedeo, Coulet, Adrien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471679/ https://www.ncbi.nlm.nih.gov/pubmed/30999867 http://dx.doi.org/10.1186/s12859-019-2693-9 |
Ejemplares similares
-
PGxCorpus, a manually annotated corpus for pharmacogenomics
por: Legrand, Joël, et al.
Publicado: (2020) -
Pharmacogenomic (PGx) Counseling: Exploring Participant Questions about PGx Test Results
por: Schmidlen, Tara, et al.
Publicado: (2020) -
HUGO Statement on Pharmacogenomics (PGx): Solidarity, Equity and Governance
Publicado: (2007) -
Pharmacogenomics (PGx) Patient with Mixed Levels of Actionable Variant Evidence
por: Schuh, Michael J., et al.
Publicado: (2020) -
Drug Use among Nursing Home Residents in Denmark for Drugs Having Pharmacogenomics Based (PGx) Dosing Guidelines: Potential for Preemptive PGx Testing
por: Vermehren, Charlotte, et al.
Publicado: (2020)